Your session is about to expire
← Back to Search
Observational for Bladder Cancer
N/A
Recruiting
Led By John B. Kisiel, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (at enrollment)
Awards & highlights
Study Summary
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
Eligible Conditions
- Bladder Cancer
- Blood in Urine
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (at enrollment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (at enrollment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood sample to support the development of non-invasive tests for early detection of bladder cancer
Urine sample to support the development of non-invasive tests for early detection of bladder cancer
Trial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo blood and urine sample collection and have their medical records reviewed while on study.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,208 Previous Clinical Trials
3,766,550 Total Patients Enrolled
John B. Kisiel, M.D.Principal InvestigatorMayo Clinic in Rochester
3 Previous Clinical Trials
16,150 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger